Snig Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.26 Cr
as on 17-07-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.70%
(FY 2022)
- Profit -49.45%
(FY 2022)
- Ebitda -53.90%
(FY 2022)
- Net Worth -7.73%
(FY 2022)
- Total Assets -7.15%
(FY 2022)
About Snig Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Renukaradhya Umashankar, Davanagere Savitha, Poornima Patil, and Four other members serve as directors at the Company.
- CIN/LLPIN
U52590KA2015PTC082351
- Company No.
082351
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2015
- Date of AGM
24 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Sahakar Nagar A Block Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Snig Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashanth Kukkalli  | Managing Director | 25-Nov-2017 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Poornima Patil | Director | 18-Aug-2015 | Current |
| Renukaradhya Umashankar | Director | 23-May-2016 | Current |
| Davanagere Savitha | Whole-Time Director | 18-Aug-2015 | Current |
| Marilinge Vivekananda | Director | 25-Nov-2017 | Current |
| Ravi Chandakavadi | Director | 25-Nov-2017 | Current |
| Raghukumar Jogad | Director | 25-Nov-2017 | Current |
Financial Performance and Corporate Structure Insights of Snig Pharma.
Snig Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.7% increase. The company also saw a substantial fall in profitability, with a 49.45% decrease in profit. The company's net worth dipped by a decrease of 7.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Snig Pharma?
In 2022, Snig Pharma had a promoter holding of 23.51% and a public holding of 76.49%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pan-Asia Hospitals Private LimitedActive 10 years 9 monthsRenukaradhya Umashankar is a mutual person
Siddaganga Diagnostic Centre Private LimitedActive 10 years 9 monthsRenukaradhya Umashankar is a mutual person
- Bengaluru Neuro Center Private LimitedActive 12 years 9 months
Renukaradhya Umashankar and Davanagere Savitha are mutual person
- Saakalya Hospitals Private LimitedActive 2 years 7 months
Renukaradhya Umashankar is a mutual person
- Shivkrupa Medical Services Private LimitedActive 9 years 10 months
Poornima Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Snig Pharma?
Snig Pharma has a workforce of 18 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Snig Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snig Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
